pcos treatment glp-1 Rising use of medications among women with GLP-1s and PMOS: PCOS, Insulin

That distinction matters clinically, especially when women account for roughly 75% of people seeking medical treatment for obesity and excess weight

2024 research from Nutrition & Diabetes outlined the economic impact of obesity related to excess medical costs, absenteeism, disability payments and workers compensation payments

MariTide is both a GLP-1 receptor agonist and a gastric inhibitory polypeptide receptor (GIPR) antagonist

The effects of spinach-derived thylakoid supplementation in combination with calorie restriction on anthropometric parameters and metabolic profiles in obese women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled clinical trial

J Intern Med

Next, side effects